Buscar
12/12/2023
Down Syndrome in a New Era for Alzheimer Disease
Rafii, MS, Fortea, J. Down Syndrome in a New Era for Alzheimer Disease. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. 2023; 330(22)DOI:10.1001/jama.2023.22924. PMID:37991807. IF:63.500(Q1/1D).
05/12/2023
Association of Blood-Based DNA Methylation Markers With Late-Onset Alzheimer Disease
Acha, B, Corroza, J, de Gordoa, JSR, Cabello, C, Robles, M, Mendez-López, I, Macías, M, Zueco, S, Roldan, M, Urdánoz-Casado, A, Jericó, I, Erro, ME, Alcolea, D, Lleo, A, Blanco-Luquin, I, Mendioroz, M. Association of Blood-Based DNA Methylation Markers With Late-Onset Alzheimer Disease. NEUROLOGY. 2023; 101(23)DOI:10.1212/WNL.0000000000207865. PMID:37827850. IF:8.400(Q1/1D).
01/12/2023
Proteomic comparison between non-purified cerebrospinal fluid and cerebrospinal fluid-derived extracellular vesicles from patients with Alzheimer's, Parkinson's and Lewy body dementia
Hirschberg, Y, Valle-Tamayo, N, Dols-Icardo, O, Engelborghs, S, Buelens, B, Vandenbroucke, RE, Vermeiren, Y, Boonen, K, Mertens, I. Proteomic comparison between non-purified cerebrospinal fluid and cerebrospinal fluid-derived extracellular vesicles from patients with Alzheimer's, Parkinson's and Lewy body dementia. Journal of Extracellular Vesicles. 2023; 12(12)DOI:10.1002/jev2.12383. PMID:38082559. IF:15.500(Q1/1D).
03/08/2023
Prevalence of treated patients with Alzheimer's disease: current trends and COVID-19 impact
Olazarán J., Carnero-Pardo C., Fortea J., Sánchez-Juan P., García-Ribas G., Vinuela, F, Martínez-Lage P., Boada M.. Prevalence of treated patients with Alzheimer's disease: current trends and COVID-19 impact. Alzheimers Research & Therapy. 2023; 15(1)DOI:10.1186/s13195-023-01271-0. PMID:37537656. IF:8.000(Q1/1D).